Friday, May 23, 2025 | 02:36 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

CureVac files patent lawsuit in Germany against BioNTech over mRNA tech

The German-based biotech company is seeking 'fair compensation' from BioNTech and two subsidiaries for infringement of its intellectual property rights

Biontech
Premium

Test tubes are seen in front of a displayed BioNTech logo in this illustration (Reuters)

Reuters Berlin
CureVac has filed a patent lawsuit in Germany against BioNTech over its use of mRNA technology, marking one of the first known cases of a company going to court amid the fierce competition to develop a vaccine against the coronavirus.

The German-based biotech company is seeking "fair compensation" from BioNTech and two subsidiaries for infringement of its intellectual property rights, it said on Tuesday.

When asked in a media call, Chief Executive Franz-Werner Haas did not rule out further legal action against BioNTech partner Pfizer or mRNA vaccine maker Moderna.

CureVac said that its claim to intellectual property rights was based on more

Disclaimer: No Business Standard Journalist was involved in creation of this content